123
  • Benitec Investor Webinar on OPMD - Duration: 1 hour.

    • 6 months ago
    • 350 views
    The presentation provides a detailed overview of oculopharyngeal muscular dystrophy (OPMD), Benitec’s BB-301 gene therapy construct, as well as the associated market opportunity and product pipeline
  • shRNA vs siRNA: Benitec's ddRNAi Explained - Duration: 2 minutes, 34 seconds.

    • 4 years ago
    • 26,715 views
  • Benitec Ltd (ASX:BLT) CEO Interview - Duration: 9 minutes, 53 seconds.

    • 7 years ago
    • 631 views
    Interview conducted by Wholesale Investor with Benitec Limited CEO Peter French
to add this to Watch Later

Add to

Loading playlists...